>유럽 폐암 검진 소프트웨어 시장, 제공 모드(클라우드 기반 솔루션, 온프레미스 솔루션 및 웹 기반 솔루션), 제품(폐암 검진 방사선 솔루션, 폐암 검진 환자 관리 소프트웨어, 결절 관리 소프트웨어, 데이터 수집 및 보고, 환자 조정 및 워크플로, 폐 결절 컴퓨터 지원 감지, 병리학 및 암 병기 분류, 통계적 감사 보고, 검진 PAC, 실무 관리 및 감사 로그 추적), 유형(컴퓨터 지원 검진 및 기존 검진), 애플리케이션(비소세포 폐암(NSCLC) 및 소세포 폐암(SCLC)), 플랫폼(독립형 및 통합), 구매 모드(기관 및 개인), 최종 사용자(종양 센터, 병원, 외래 수술 센터 및 기타), 유통 채널(직접 입찰 및 제3자 유통업체) - 업계 동향 및 2029년까지의 예측.
유럽 폐암 검진 소프트웨어 시장 분석 및 규모
폐암 사망률 통제는 의료 시설의 주요 관심사 중 하나입니다. 공공 및 민간 기관은 사망률을 통제하기 위한 검진 프로그램을 시작하기 위한 이니셔티브를 취하고 있습니다. 또한, 회사는 환자 데이터 관리를 용이하게 하고 엄격한 데이터 개인 정보 보호 지침으로 더 나은 치료를 제공하기 위한 고급 소프트웨어를 출시하고 있습니다.
폐암 유병률 증가, 폐암에 대한 사람들의 인식 증가, 정부 이니셔티브 증가, 검진 프로그램 수 증가는 시장 성장을 견인하는 주요 요인 중 일부입니다. 또한, 주요 시장 참여자의 인공지능(AI) 기반 솔루션과 전략적 이니셔티브의 발전은 폐암 검진 소프트웨어 분야에서 기회를 창출하고 있습니다.
그러나 데이터 개인정보 보호 문제와 비숙련 노동력 부족이 예측 기간 동안 시장 성장을 방해할 것으로 예상됩니다.
Data Bridge Market Research는 유럽 폐암 검진 소프트웨어 시장이 2029년까지 27,518.34만 달러에 도달할 것으로 예상하고 있으며, 예측 기간 동안 CAGR은 19.6%입니다. 클라우드 기반 솔루션은 시장에서 가장 큰 제공 모드 세그먼트를 차지합니다. 시장 보고서는 또한 가격 분석, 특허 분석 및 기술 발전에 대한 심층적인 내용을 다룹니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2022년부터 2029년까지 |
|
기준 연도 |
2021 |
|
역사적 연도 |
2020 (2019-2014로 사용자 정의 가능) |
|
양적 단위 |
수익은 천 달러, 가격은 달러로 표시됨 |
|
다루는 세그먼트 |
By Mode of Delivery (Cloud Based Solutions, On-Premise Solutions and Web Based Solutions), Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management and Audit Log Tracking), Type (Computer-Assisted Screening and Traditional Screening), Application (Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)), Platform (Standalone and Integrated), Purchase Mode (Institutional and Individual), End User (Oncology Centers, Hospitals, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender and Third Party Distributors) |
|
Countries Covered |
Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium and rest of Europe |
|
Market Players Covered |
PenRad Technologies Inc., Koninklijke Philips N.V, Volpara Health Limited, Thynk Health, Nuance Communications, Inc., Siemens Healthcare GmbH, MyCareWare, Inc., MagView, MeVis Medical Solutions AG, Canon Medical Informatics, Inc., General Electric Company, Epic Systems Corporation, Lungview, Eon, Medtronic, Coreline Soft Co., Ltd., Optellum Ltd, HealthMyne, Oncocyte Corporation, Genesystem, REVEALDX, FUJIFILM Holdings Corporation, F. Hoffmann-La Roche Ltd, Median Technologies, AstraZeneca, and Aidence.com |
Market Definition
Lung cancer screening is identifying stages of lung cancer using different technologies and software. Lung cancer screening using CT is the most recommended technique for screening lung cancer. The rising use of this technique is expected to accelerate the need for advanced software for lung cancer screening. This software helps to manage patients’ participation in lung screening programs and provides an efficient way for healthcare professionals to collect, curate, and transfer data to clinicians and patients. In addition, this software enables in the identification of patients at risk and automates the flow of data with integrated electronic health records.
Europe Lung Cancer Screening Software Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints and challenges. All of this is discussed in detail below:
Drivers
- Increase in prevalence of lung cancer cases globally
Lung cancer is a leading cause of death in men and women. According to World Cancer Research Fund International, lung cancer is the second most common cancer worldwide. It is the most common cancer in men and second most common in women. There were more than 2.2 thousand new cases of lung cancer in 2020. Increasing prevalence of lung cancer cases creates need to adopt lung cancer screening software for early diagnosis and acts as a driving factor for the market growth.
- Increase in awareness regarding the benefits of early diagnosis and frequent screening
The rising awareness programs of lung cancer by public, non-profit, and private organization are anticipated to boost the market growth. These initiatives aim to prevent diseases, reduce stigma and prejudice, and promote research. The awareness among the population regarding lung cancer has increased. Because there are many awareness programs by different organizations, people know about lung cancer that can be cured if diagnosed early. Thus, raising awareness among populations is driving the market growth.
- Government initiatives were undertaken to implement screening programs for various diseases
The burden of cancer continues to increase globally and has great financial, emotional, and physical stress on health systems, products, families, and individuals. In countries with strong health systems, the survival rate of many types of cancer is improved due to survivorship, quality care, increased awareness, and accessible early detection. Centers for Disease Control and Prevention, U.S., tribes, and the U.S.-Pacific islands and territories through the National Comprehensive Cancer Control Program (NCCCP) are to form or support alliances to combat cancer in their communities. Due to these initiatives, more audiences are educated and more consciously dispersed, pushing the global audience to take further precautions and practice preventive examinations, promoting the market.
- Growing number of screening programs across the globe
Screening is an effective method of detecting early-stage cancer. There is an increasing trend in lung cancer incidences in developing countries. Although there are regular recommendations for screening for breast and cervical cancer, it is not the same in the case of lung cancer. Most countries or institutions have initiated the feasibility and disease screening of Low-Dose Computed Tomography (LDCT) for lung cancer. The increasing number of lung cancer screening has created an opportunity for the market players. Hence, the increasing diagnostic rate acts as a driving factor for market growth.
Opportunity
-
Rising collaborations, mergers & acquisitions among the market players
The companies operating in the market are adopting several strategies, including mergers and acquisitions, product launches, agreements, pipeline development, collaborations, and market expansion among others, to boost their business in various dimensions. These strategic decisions by the companies are expected to offer significant opportunities for the market players operating in the market.
Restraint/Challenge
- Issues related to the availability of software
There are certain issues/barriers related to effective and efficient lung cancer screening and the availability of lung cancer screening software in developing nations. Issues are competing demands for time, knowledge about lung cancer screening, evolving attitudes about the effectiveness of screening, nihilism related to historically poor lung cancer treatment outcomes, and limited training and requirement approval for local authorities or country medical device regulatory body. All these issues delay launches and availability of the product. Also, the demand for lung cancer screening software is hampered due to technical issues related to the available software thereby, acting as a restraint for market growth.
Post-COVID-19 Impact on Europe Lung Cancer Screening Software Market
COVID-19 created a major impact on various industries as almost every country opted for the shutdown of every facility except the ones dealing in the essential goods segment. The government took some strict actions such as the shutdown of facilities and sale of non-essential goods, blocking international trade, and many more to prevent the spread of COVID-19. The only business which was running during this pandemic situation was the essential services that were allowed to open and run the processes.
COVID-19 created new and unfamiliar challenges for healthcare providers to deliver patient care. Many non-essential but important services such as lung cancer screening were temporarily suspended to protect the health of staff and patients. Healthcare institutions faced unprecedented challenges regarding scheduling, patient monitoring, and follow-up of patient-service communication to ensure continuity of care during COVID-19 and when services could be continued safely. COVID-19 created new challenges for lung cancer screening programs, in many cases, delaying screening by several months and creating more difficulties for management and scheduling teams. Although the COVID-19 crisis shed new light on the importance of respiratory assistance, it will hopefully have a major impact on reducing stigma of screening for cancer. There are more than 10,000,000 eligible patients in the U.S. who are eligible for lung cancer screening, less than 5 percent of whom are actively enrolled in the screening program. COVID-19 created a negative impact on the market.
However, the lung cancer screening software companies are struggling and continuously taking different strategic decisions to control the situation. The players are involved in strategic activities such as partnerships, collaborations, and mergers & acquisitions among others to improve the technology involved in the market. With this, the companies will bring advanced and accurate solutions to the market. In addition, the government initiatives to boost digitization across industries have also led to market growth.
Recent Developments
- In July 2022, GE Healthcare launched their latest product and most advanced ultrasound, the next-generation Voluson Expert 22. This latest addition to GE Healthcare’s award-winning Women’s Health portfolio utilizes graphic-based beam former technology, which produces higher quality images and offers greater flexibility in imaging functions. With this product, the company made its position much stronger in the area of products and service providers to healthcare institutions.
- In October 2021, Thynk Health announced a partnership with Infervision, to fight lung cancer with the world’s most advanced technologies. It offers an opportunity for lung cancer screening and pulmonary nodule management. With this partnership, the company increased its market presence.
Europe Lung Cancer Screening Software Market Scope
Europe lung cancer screening software market is segmented into eight notable segments based on mode of delivery, product, type, application, platform, purchase mode, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Mode of Delivery
- Cloud Based Solutions
- On-Premise Solutions
- Web Based Solutions
On the basis of mode of delivery, the market is segmented into cloud based solutions, on-premise solutions, and web based solutions.
Product
- Lung Cancer Screening Radiology Solution
- Lung Cancer Screening Patient Management Software
- Nodule Management Software
- Data Collection and Reporting
- Patient Coordination and Workflow
- Lung Nodule Computer Aided Detection
- Pathology and Cancer Staging
- Statistical Audit Reporting
- Screening PACS
- Practice Management
- Audit Log Tracking
On the basis of product, the market is segmented into lung cancer screening radiology solution, lung cancer screening patient management software, nodule management software, data collection and reporting, patient coordination and workflow, lung nodule computer aided detection, pathology and cancer staging, statistical audit reporting, screening PACS, practice management, and audit log tracking.
Type
- Computer-Assisted Screening
- Traditional Screening
On the basis of type, the market is segmented into computer-assisted screening and traditional screening.
Application
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
On the basis of application, the market is segmented into Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).
Platform
- Standalone
- Integrated
On the basis of platform, the market is segmented into standalone and integrated.
Purchase Mode
- Institutional
- Individual
On the basis of purchase mode, the market is segmented into individual and institutional.
End User
- Oncology Centers
- Hospitals
- Ambulatory Surgical Centers
- Others
On the basis of end user, the market is segmented into hospitals, oncology centers, ambulatory surgical centers, and others.
유통 채널별
- 직접 입찰
- 제3자 유통업체
유통 채널을 기준으로 시장은 직접 입찰과 제3자 유통업체로 구분됩니다.
유럽 폐암 검진 소프트웨어 시장 지역 분석/통찰력
유럽 폐암 검진 소프트웨어 시장을 분석하고, 위에 언급된 대로 제공 방식, 제품, 유형, 애플리케이션, 플랫폼, 구매 방식, 최종 사용자 및 유통 채널을 기반으로 시장 규모에 대한 통찰력과 추세를 제공합니다.
이 시장 보고서에서 다루는 국가는 독일, 영국, 프랑스, 이탈리아, 스페인, 네덜란드, 러시아, 스위스, 터키, 벨기에 및 기타 유럽 국가입니다. 독일은 폐암이 유럽에서 암 사망의 주요 원인이기 때문에 시장을 지배하고 있으며, 이로 인해 조기 진단을 위한 폐암 검진 소프트웨어를 채택해야 할 필요성이 생깁니다. 게다가 유럽 지역의 우세한 정교한 수준의 의료 시설도 이 지역의 시장이 엄청나게 성장하는 데 기여했습니다.
보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규제의 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 추세 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 유럽 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세의 영향 및 무역 경로가 국가 데이터의 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 유럽 폐암 검진 소프트웨어 시장 점유율 분석
유럽 폐암 검진 소프트웨어 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 유럽의 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 제공된 위의 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.
이 시장에서 활동하는 주요 기업으로는 PenRad Technologies Inc., Koninklijke Philips NV, Volpara Health Limited, Thynk Health, Nuance Communications, Inc., Siemens Healthcare GmBH, MyCareWare, Inc., MagView, MeVis Medical Solutions AG, Canon Medical Informatics, Inc., General Electric Company, Epic Systems Corporation, Lungview, Eon, Medtronic, Coreline Soft, Co., Ltd., Optellum Ltd, HealthMyne, Oncocyte Corporation, Genesystem, REVEALDX, FUJIFILM Holdings Corporation, F. Hoffmann-La Roche Ltd, Median Technologies, AstraZeneca, Aidence.com 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of Europe lung cancer screening software market
- LIMITATION
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- market application coverage grid
- mode of delivery LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insights
- REGULATIONS & REIMBURSEMENT
- IMPACT OF COVID-19 PANDEMIC ON THE MARKET
- Price impact
- Impact on demand
- IMPACT ON SUPPLY CHAIN
- STRATEGIC DECISIONS FOR MANUFACTURERS
- CONCLUSION
- Market Overview
- drivers
- Increasing prevalence of lung cancer cases Europely
- Increasing awareness regarding the benefits of early diagnosis and frequent screening
- Government initiatives undertaken to implement screening programs for various diseases
- Growing number of screening programs across the globe
- Technological advancementS in THE field of healthcare
- RESTRAINTS
- issues related with the availability of software
- Scarcity of technically knowledgeable professionals for cancer diagnosis
- Lack of funding and other resources from various regions for cancer and associated disorders
- OPPORTUNITIES
- Rising collaborations, mergerS & acquisitions among the market players
- Increasing investmentS in healthcare segmentS
- Multiple benefits associated with lung cancer screening software
- CHALLENGES
- High cost of screening software and related services
- Increasing challenges related to development of lung cancer screening software
- Increasing competition in the market
- EUROPE lung cancer screening software MARKET, BY MODE OF DELIVERY
- overview
- Cloud Based Solutions
- On-Premise Solutions
- Web Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT
- overview
- Lung Cancer Screening Radiology Solution
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Lung Cancer Screening Patient Management Software
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Nodule Management Software
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Data Collection and Reporting
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Patient Coordination and Workflow
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Lung Nodule Computer Aided Detection
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Pathology and Cancer Staging
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Statistical Audit Reporting
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Screening PACs
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Practice Management
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Audit Log Tracking
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY type
- overview
- Computer-Assisted Screening
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Traditional Screening
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY application
- overview
- Non-Small Cell Lung Cancer (NSCLC)
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Small Cell Lung Cancer (SCLC)
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY platform
- overview
- Standalone
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Integrated
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY Purchase Mode
- overview
- Institutional
- INDIVIDUAL
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY end user
- overview
- Oncology Centers
- Hospitals
- Ambulatory Surgical Centers
- Others
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY Distribution Channel
- overview
- Direct Tenders
- Third Party Distributor
- Europe lung cancer screening software Market, by Geography
- Europe
- germany
- France
- U.K
- Italy
- SPAIN
- NETHERLANDS
- RUSSIA
- Switzerland
- BELGIUM
- Philippines
- Rest of Europe
- Europe Lung cancer screening software market, COMPANY landscape
- company share analysis: Europe
- Swot analysis
- CompanY profiles
- KONINKLIJKE PHILIPS N.v
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Nuance Communications, Inc.
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Siemens Healthcare GmbH
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Lungview
- COMPANY SNAPSHot
- company share analysis
- Solution Portfolio
- RECENT DEVELOPMENT
- Medtronic
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Thynk health
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- Vital Images (A subsidiary of Canon Group Company)
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- MeVis Medical Solutions AG
- COMPANY SNAPSHot
- Revenue analysis
- product Portfolio
- RECENT DEVELOPMENTS
- HealthMyne
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENTS
- Volpara Solutions Limited
- COMPANY SNAPSHot
- Revenue analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Coreline Soft, Co., Ltd.
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENTS
- EON
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENT
- MyCareWare Inc
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENT
- Optellum Ltd
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- PenRad Technologies Inc.
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENT
- ProVation Medical, Inc.
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENTS
- questionnaire
- related reports
표 목록
TABLE 1 Europe Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 2 Europe Cloud Based Solutions in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand)
TABLE 3 Europe On-Premise Solutions in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand)
TABLE 4 Europe Web Based Solutions in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand)
TABLE 5 Europe Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 6 Europe Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 7 Europe Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 8 Europe Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 9 Europe Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 10 Europe Nodule Management Software in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 11 Europe Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 12 Europe Data Collection and Reporting in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 13 Europe Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 14 Europe Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 15 Europe Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 16 Europe Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 17 Europe Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 18 Europe Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 19 Europe Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 20 Europe Statistical Audit Reporting in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 21 Europe Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 22 Europe Screening PACs in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 23 Europe Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 24 Europe Practice Management in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 25 Europe Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 26 Europe Audit Log Tracking in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 27 Europe Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 28 Europe Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 29 Europe Computer-Assisted Screening in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 30 Europe Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 31 Europe Traditional Screening in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 32 Europe Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 33 Europe Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 34 Europe Non-Small Cell Lung Cancer (NSCLC) in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 35 Europe Non-Small Cell Lung Cancer (NSCLC) in Lung Cancer Screening Software Market, By Product Type, 2018-2027 (USD Thousand)
TABLE 36 Europe Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 37 Europe Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 38 Europe Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 39 Europe Standalone in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 40 Europe Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 41 Europe Integrated in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 42 Europe Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 43 Europe Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 44 Europe Institutional in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 45 Europe Individual in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 46 Europe Lung Cancer Screening Software Market, By end user, 2018-2027 (USD Thousand)
TABLE 47 Europe Oncology Centers in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 48 Europe Hospitals in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 49 Europe Ambulatory Surgical Centers in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 50 Europe Others in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 51 Europe Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 52 Europe Direct Tenders in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 53 Europe Third Party Distributor in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 54 EUROPE LUNG CANCER SCREENING SOFTWARE market, By Country, 2018–2027 (USD thousand)
TABLE 55 Europe Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 56 Europe Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 57 Europe Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 58 Europe Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 59 Europe Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 60 Europe Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 61 Europe Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 62 Europe Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 63 Europe Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 64 Europe Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 65 Europe Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 66 Europe Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 67 Europe Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 68 Europe Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 69 Europe Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 70 Europe Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 71 Europe Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 72 Europe Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 73 Europe Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 74 Europe Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 75 Europe Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 76 Europe Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 77 Europe Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 78 Europe Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 79 Europe Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 80 Germany Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 81 Germany Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 82 Germany Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 83 Germany Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 84 Germany Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 85 Germany Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 86 Germany Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 87 Germany Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 88 Germany Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 89 Germany Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 90 Germany Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 91 Germany Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 92 Germany Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 93 Germany Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 94 Germany Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 95 Germany Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 96 Germany Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 97 Germany Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 98 Germany Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 99 Germany Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 100 Germany Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 101 Germany Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 102 Germany Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 103 Germany Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 104 Germany Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 105 France Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 106 France Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 107 France Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 108 France Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 109 France Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 110 France Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 111 France Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 112 France Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 113 France Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 114 France Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 115 France Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 116 France Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 117 France Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 118 France Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 119 France Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 120 France Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 121 France Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 122 France Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 123 France Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 124 France Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 125 France Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 126 France Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 127 France Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 128 France Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 129 France Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 130 U.K Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 131 U.K Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 132 U.K Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 133 U.K Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 134 U.K Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 135 U.K Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 136 U.K Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 137 U.K Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 138 U.K Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 139 U.K Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 140 U.K Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 141 U.K Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 142 U.K Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 143 U.K Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 144 U.K Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 145 U.K Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 146 U.K Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 147 U.K Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 148 U.K Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 149 U.K Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 150 U.K Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 151 U.K Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 152 U.K Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 153 U.K Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 154 U.K Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 155 Italy Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 156 Italy Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 157 Italy Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 158 Italy Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 159 Italy Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 160 Italy Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 161 Italy Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 162 Italy Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 163 Italy Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 164 Italy Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 165 Italy Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 166 Italy Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 167 Italy Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 168 Italy Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 169 Italy Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 170 Italy Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 171 Italy Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 172 Italy Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 173 Italy Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 174 Italy Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 175 Italy Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 176 Italy Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 177 Italy Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 178 Italy Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 179 Italy Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 180 Spain Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 181 Spain Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 182 Spain Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 183 Spain Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 184 Spain Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 185 Spain Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 186 Spain Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 187 Spain Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 188 Spain Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 189 Spain Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 190 Spain Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 191 Spain Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 192 Spain Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 193 Spain Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 194 Spain Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 195 Spain Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 196 Spain Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 197 Spain Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 198 Spain Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 199 Spain Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 200 Spain Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 201 Spain Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 202 Spain Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 203 Spain Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 204 Spain Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 205 Netherlands Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 206 Netherlands Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 207 Netherlands Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 208 Netherlands Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 209 Netherlands Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 210 Netherlands Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 211 Netherlands Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 212 Netherlands Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 213 Netherlands Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 214 Netherlands Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 215 Netherlands Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 216 Netherlands Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 217 Netherlands Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 218 Netherlands Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 219 Netherlands Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 220 Netherlands Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 221 Netherlands Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 222 Netherlands Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 223 Netherlands Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 224 Netherlands Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 225 Netherlands Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 226 Netherlands Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 227 Netherlands Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 228 Netherlands Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 229 Netherlands Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 230 Russia Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 231 Russia Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 232 Russia Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 233 Russia Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 234 Russia Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 235 Russia Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 236 Russia Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 237 Russia Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 238 Russia Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 239 Russia Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 240 Russia Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 241 Russia Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 242 Russia Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 243 Russia Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 244 Russia Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 245 Russia Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 246 Russia Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 247 Russia Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 248 Russia Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 249 Russia Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 250 Russia Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 251 Russia Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 252 Russia Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 253 Russia Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 254 Russia Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 255 Switzerland Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 256 Switzerland Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 257 Switzerland Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 258 Switzerland Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 259 Switzerland Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 260 Switzerland Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 261 Switzerland Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 262 Switzerland Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 263 Switzerland Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 264 Switzerland Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 265 Switzerland Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 266 Switzerland Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 267 Switzerland Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 268 Switzerland Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 269 Switzerland Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 270 Switzerland Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 271 Switzerland Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 272 Switzerland Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 273 Switzerland Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 274 Switzerland Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 275 Switzerland Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 276 Switzerland Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 277 Switzerland Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 278 Switzerland Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 279 Switzerland Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 280 Belgium Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 281 Belgium Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 282 Belgium Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 283 Belgium Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 284 Belgium Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 285 Belgium Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 286 Belgium Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 287 Belgium Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 288 Belgium Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 289 Belgium Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 290 Belgium Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 291 Belgium Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 292 Belgium Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 293 Belgium Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 294 Belgium Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 295 Belgium Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 296 Belgium Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 297 Belgium Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 298 Belgium Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 299 Belgium Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 300 Belgium Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 301 Belgium Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 302 Belgium Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 303 Belgium Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 304 Belgium Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 305 Turkey Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 306 Turkey Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 307 Turkey Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 308 Turkey Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 309 Turkey Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 310 Turkey Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 311 Turkey Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 312 Turkey Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 313 Turkey Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 314 Turkey Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 315 Turkey Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 316 Turkey Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 317 Turkey Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 318 Turkey Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 319 Turkey Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 320 Turkey Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 321 Turkey Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 322 Turkey Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 323 Turkey Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 324 Turkey Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 325 Turkey Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 326 Turkey Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 327 Turkey Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 328 Turkey Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 329 Turkey Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 330 REST of Asia Pacific Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
그림 목록
FIGURE 1 Europe lung cancer screening software market: segmentation
FIGURE 2 Europe lung cancer screening software market: data triangulation
FIGURE 3 Europe lung cancer screening software market: DROC ANALYSIS
FIGURE 4 Europe lung cancer screening software market: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 Europe lung cancer screening software market: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE Lung cancer screening software MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 7 Europe lung cancer screening software market: INTERVIEW DEMOGRAPHICS
FIGURE 8 Europe lung cancer screening software market: DBMR MARKET POSITION GRID
FIGURE 9 Europe lung cancer screening software market: vendor share analysis
FIGURE 10 Europe lung cancer screening software market: SEGMENTATION
FIGURE 11 RISING lung cancer screening programs and Technological advancement in THE field of healthcare is expected to drive THE Europe lung cancer screening software market IN THE FORECAST PERIOD of 2020 to 2027
FIGURE 12 Cloud based solutions segment is expected to account for the largest share of Europe lung cancer screening software market in 2020 & 2027
FIGURE 13 Drivers, RestrainTs, OPPORTUNITIES & challenges OF Europe Lung Cancer Screening Software market
FIGURE 14 Lung Cancer incidence and mortality rates, 2018
FIGURE 15 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY mode of delivery, 2019
FIGURE 16 Europe Lung cancer screening software market: BY Mode of Delivery, 2019-2027 (USD Thousand)
FIGURE 17 Europe Lung cancer screening software market: BY Mode of Delivery, CAGR (2020-2027)
FIGURE 18 Europe Lung cancer screening software market: BY Mode of Delivery, LIFELINE CURVE
FIGURE 19 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY product, 2019
FIGURE 20 Europe Lung cancer screening software market: BY product, 2019-2027 (USD Thousand)
FIGURE 21 Europe Lung cancer screening software market: BY product, CAGR (2020-2027)
FIGURE 22 Europe Lung cancer screening software market: BY product, LIFELINE CURVE
FIGURE 23 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY type, 2019
FIGURE 24 Europe Lung cancer screening software market: BY type, 2019-2027 (USD Thousand)
FIGURE 25 Europe Lung cancer screening software market: BY type, CAGR (2020-2027)
FIGURE 26 Europe Lung cancer screening software market: BY type, LIFELINE CURVE
FIGURE 27 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY application, 2019
FIGURE 28 Europe Lung cancer screening software market: BY application, 2019-2027 (USD Thousand)
FIGURE 29 Europe Lung cancer screening software market: BY application, CAGR (2020-2027)
FIGURE 30 Europe Lung cancer screening software market: BY application, LIFELINE CURVE
FIGURE 31 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY platform, 2019
FIGURE 32 Europe Lung cancer screening software market: BY platform, 2019-2027 (USD Thousand)
FIGURE 33 Europe Lung cancer screening software market: BY platform, CAGR (2020-2027)
FIGURE 34 Europe Lung cancer screening software market: BY platform, LIFELINE CURVE
FIGURE 35 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY Purchase Mode, 2019
FIGURE 36 Europe Lung cancer screening software market: BY Purchase Mode, 2019-2027 (USD Thousand)
FIGURE 37 Europe Lung cancer screening software market: BY Purchase Mode, CAGR (2020-2027)
FIGURE 38 Europe Lung cancer screening software market: BY Purchase Mode, LIFELINE CURVE
FIGURE 39 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY end user, 2019
FIGURE 40 Europe Lung cancer screening software market: BY end user, 2019-2027 (USD Thousand)
FIGURE 41 Europe Lung cancer screening software market: BY end user, CAGR (2020-2027)
FIGURE 42 Europe Lung cancer screening software market: BY end user, LIFELINE CURVE
FIGURE 43 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY Distribution Channel, 2019
FIGURE 44 Europe Lung cancer screening software market: BY distribution channel, 2019-2027 (USD Thousand)
FIGURE 45 Europe Lung cancer screening software market: BY distribution channel, CAGR (2020-2027)
FIGURE 46 Europe Lung cancer screening software market: BY distribution channel, LIFELINE CURVE
FIGURE 47 EUROPE Lung cancer screening software MARKET: SNAPSHOT (2019)
FIGURE 48 EUROPE Lung cancer screening software MARKET: by COUNTRY (2020)
FIGURE 49 EUROPE Lung cancer screening software MARKET: by COUNTRY (2019 & 2027)
FIGURE 50 EUROPE Lung cancer screening software MARKET: by COUNTRY (2019 & 2027)
FIGURE 51 EUROPE Lung cancer screening software MARKET: by TYPE (2020-2027)
FIGURE 52 Europe Lung cancer screening software market: company share 2019 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
